InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
76.59
(
0.35%
)
Bitcoin
57,549.35
(
0.39%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

juk

Send PM Follow Ignore
Followers 0
Posts 1820
Boards Moderated 0
Alias Born 11/13/2008

juk

Re: Stockrockdrummer post# 17692

Thursday, 05/28/2009 10:15:46 AM

Thursday, May 28, 2009 10:15:46 AM

Post# of 92948
Stockrockdrummer wrote:
But the retinal program requires embryos********************

Yeah so?

Geron Corporation Receives FDA Clearance To Begin First Human Clinical Trial
Friday, 23 Jan 2009 07:30am EST
Geron Corporation announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the Company's Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury. The clearance enables Geron to move forward with the study of a human embryonic stem (hESC) cell-based therapy in man.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up